Impaired Fasting Glucose in Hypertensive Patients: Prevalence and Cross-Sectional Analysis of Associations with Cardiovascular Disease
| Autor: | Natalia Papastergiou, Konstantia Psianou, Fotios Iliadis, Christos Savopoulos, Konstantinos Tziomalos, M. Baltatzi, Apostolos I. Hatzitolios, Marianna Spanou, Elias Efthymiou, Triandafillos P. Didangelos |
|---|---|
| Rok vydání: | 2013 |
| Předmět: |
Adult
Blood Glucose Male medicine.medical_specialty endocrine system diseases Cross-sectional study Endocrinology Diabetes and Metabolism Adrenergic beta-Antagonists Population Disease behavioral disciplines and activities Endocrinology Risk Factors Internal medicine Diabetes mellitus Glucose Intolerance Prevalence medicine Humans In patient Diuretics education Antihypertensive Agents Aged education.field_of_study Greece business.industry nutritional and metabolic diseases Fasting Middle Aged medicine.disease Impaired fasting glucose Coronary heart disease Stroke Medical Laboratory Technology Cross-Sectional Studies Cardiovascular Diseases Serum glucose Hypertension Female business hormones hormone substitutes and hormone antagonists psychological phenomena and processes Follow-Up Studies |
| Zdroj: | Diabetes Technology & Therapeutics. 15:475-480 |
| ISSN: | 1557-8593 1520-9156 |
| DOI: | 10.1089/dia.2012.0336 |
| Popis: | Impaired fasting glucose (IFG) is frequently present in hypertensive patients and might be induced or aggravated by antihypertensive treatment. However, it is unclear whether IFG is associated with increased cardiovascular risk in this population.We performed a cross-sectional study in 1,810 hypertensive patients and recorded the presence of IFG, coronary heart disease (CHD), and ischemic stroke.IFG was present in 567 patients (31.3%). The prevalence of CHD or ischemic stroke did not differ between patients with IFG and in patients with serum glucose levels100 mg/dL. Among patients with IFG, 267 (47.0%) were on β-blockers, diuretics, or both β-blockers and diuretics. The prevalence of CHD was numerically but not significantly higher in patients with IFG treated with β-blockers or both β-blockers and diuretics than in patients with IFG treated with diuretics or not treated with either β-blockers or diuretics and patients with serum glucose levels100 mg/dL (11.1%, 13.6%, 1.4%, 3.7%, and 5.9%, respectively; P=not significant). The prevalence of ischemic stroke did not differ among these groups.IFG does not appear to be associated with increased prevalence of cardiovascular disease in hypertensive patients, regardless if it is associated with the antihypertensive treatment or not. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|